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Abstract: New Ru(II) arene complexes of formula [(η6-p-cym)Ru(N-N)(X)]2+ (where  
p-cym = para-cymene, N-N = 2,2'-bipyrimidine (bpm) or 2,2'-bipyridine (bpy) and  
X = m/p-COOMe-Py, 1–4) were synthesised and characterized, including the molecular  
structure of complexes [(η6-p-cym)Ru(bpy)(m-COOMe-Py)]2+ (3) and [(η6-p-cym)Ru(bpy) 
(p-COOMe-Py)]2+ (4) by single-crystal X-ray diffraction. Complexes 1–4 are stable in the 
dark in aqueous solution over 48 h and photolysis studies indicate that they can 
photodissociate the monodentate m/p-COOMe-Py ligands selectively with yields lower 
than 1%. DFT and TD-DFT calculations (B3LYP/LanL2DZ/6-31G**) performed on 
singlet and triplet states pinpoint a low-energy triplet state as the reactive state responsible 
for the selective dissociation of the monodentate pyridyl ligands.   
OPEN ACCESS
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1. Introduction 
Fuelled by the success of photodynamic therapy (PDT) [1], photoactivation of transition metal 
complexes for application in biology and medicine has gained momentum and several promising 
families of complexes have been developed in the last few years as alternative PDT agents for the 
treatment of precancerous and cancerous diseases [2,3]. As in the case of PDT, light activation allows 
in principle to obtain temporal control on the cellular effects of metal complexes and to localize their 
action exclusively in the vicinity of the irradiated tissues. Metal complexes could in principle work through 
different mechanisms of action to those of currently employed photosensitizers [4,5], a fine prospect since 
the PDT mechanism relies on the presence of oxygen and many solid tumours are hypoxic [6]. 
Nevertheless, photochemotherapy is not the only field where photoactivatable complexes have been 
applied and other research areas have benefitted from the development of light-triggerable systems. 
Examples are metal-based caged compounds for the controlled delivery of neurotransmitters [7,8]  
(e.g., γ-aminobutyric and glutamic acid) and small active molecules such as NO [9,10] and CO [11] 
which exert various bioregulative roles in organisms. 
Among the various classes of photoactivatable complexes, Ru(II) arene derivatives of the type  
[(η6-arene)Ru(N-N)(X)]2+ (where for example arene = para-cymene and N-N = bidentate chelating 
ligand) were reported by Sadler and co-workers to be promising systems for their anticancer  
properties [12] and more recently also for their photochemical features (e.g., N-N = bpm) [13,14]. It 
was shown that when the monodentate X ligand is a pyridine or a substituted pyridine these complexes 
are extremely stable in aqueous solution in the dark, but they can be selectively photoreleased upon  
light excitation. Controlling this process with light holds promise since reactive aqua species as  
[(η6-arene)Ru(N-N)(OH2)]2+ can be generated in situ, potentially triggering the biological activity of  
the complexes. 
In this contribution, we report on new complexes of the family [(η6-p-cym)Ru(N-N)(X)]2+ (Figure 1) 
(1–4) and discuss their structural, chemical and photochemical properties, including the X-ray structure 
for complexes 3 and 4. The ester group on the pyridyl ligand plays a key role in conferring dark stability 
to all derivatives, a fundamental requirement for photoactivatable prodrugs. DFT-based computational 
methods were successfully used to obtain insights on the singlet and triplet excited states, allowing 
individuation of the dissociative state responsible for the photochemical behaviour of 1–4.  
2. Results and Discussion 
2.1. Synthesis and X-ray Crystal Structures 
The complexes [(η6-p-cym)Ru(N-N)(X)]2+(where p-cym = para-cymene, 1–4) studied in this work 
were synthesized as PF6 salts in good to moderate yields and are shown in Figure 1. Complex 2 was 
previously reported by some of us [13]. The synthetic route involved the reaction of the corresponding 
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[(η6-p-cym)Ru(N-N)Cl][PF6] complex [15] with AgNO3 in a 1:1 mixture of MeOH/H2O to generate 
the corresponding aqua species [(η6-p-cym)Ru(N-N)(OH2)]2+, to which an excess of the appropriate 
ligand X and KPF6 were added. All the synthesized complexes were fully characterized by 
spectroscopic and analytical methods and are consistent with the structures depicted in Figure 1. 
 
Figure 1. Structures of the Ru(II) arene complexes studied in this work. 
The molecular structure of complexes 3 and 4 were determined by single-crystal X-ray diffraction. 
Crystals suitable for X-ray diffraction were obtained by slow evaporation of solutions of the 
complexes made up of water/methanol and acetone in the presence of excess KPF6 at ambient 
temperature. The molecular structure diagrams of the cations with numbering schemes are shown in 
Figure 2, the crystallographic data are listed in Table 1, while details of the crystal packing are 
reported in the Supporting Information (Supplementary Figures S1 and S2). Selected bond lengths and 
angles are given in Table 2 and Supplementary Table S1. These complexes have very similar structural 
features and adopt the familiar pseudo-octahedral half sandwich piano stool geometry common to 
other Ru(II) arene derivatives [15]. 
 
Figure 2. X-ray structures present in the asymmetric unit of cations [(η6-p-cym)Ru(bpy) 
(m-COOCH3-Py)]2+ (3, left) and [(η6-p-cym)Ru(bpy)(p-COOCH3-Py)]2+ (4, right). One of 
the four independent structures found in the unit cell of [(η6-p-cym)Ru(bpy)(m-COOCH3-Py)]2+ 
(3) is shown here. Thermal ellipsoids are depicted at the 50% probability level. The 
counter ions (PF6−) and the H atoms are omitted for clarity. The fully labelled structures 
and their crystal packing are depicted in the Supporting Information (Supplementary 
Figures S1 and S2). 
Molecules 2015, 20 7279 
 
 
Table 1. Crystal data and structural refinement parameters for 3 and 4.  
 3(PF6)2 4(PF6)2 
Empirical Formula C27H29F12N3O2P2Ru C27H29F12N3O2P2Ru 
Formula weight (g·mol−1) 818.54 818.54 
Crystal system Monoclinic Monoclinic 
Crystal size/mm 0.52 × 0.20 × 0.10 0.50 × 0.21 × 0.16 
Space group P2(1) P2(1)/c  
Crystal Red block Dark-red block 
a/Å 18.2866(3) 14.14530(10) 
b/Å 9.55390(12) 18.6107(2) 
c/Å 36.8439(5) 11.70990(10) 
α/deg 90.00 90.00 
β/deg 102.5101(10) 101.8020(10) 
γ/deg 90.00 90.00 
Volume/Å3 6284.10(15) 3017.51(5) 
Temperature/K 100(1) 100(1) 
Z 8 4 
μ (CuKα) [mm−1] 0.704 0.733 
Reflections collected 47851 20749 
Independent reflections [Rint] 18934 [0.032] 5932 [0.028] 
Parameters/restraints 2176/434 491/96 
R1 [a], wR2 [b] [I > 2σ (I)] 0.0487, 0.1027  0.0255, 0.0552 
R1 [a], wR2 [b] (all data) 0.0516, 0.1043 0.0295, 0.0577 
GoF [c] 1.108 1.108 
Δρ max and min/eÅ−3 1.85 and −0.713 0.573 and −0.433 
[a] R1 = Σ||Fo| − |Fc||/Σ|Fo|; [b] wR2 = [Σw(Fo2 − Fc2)2/ΣwFo2)]1/2; [c] GoF = [Σw(Fo2 – Fc2)2/(n − p)]1/2  
where n = number of reflections and p = number of parameters. 
Table 2. Selected bond distances (Å) and angles (°) for 3 and 4. In the case of 3 the mean 
values of the four independent structures present in the unit cell are reported, the data for 
all the structures are reported in the Supporting Information. 
Bond Length (Å)/Angle (°) 3 4 
Ru–arene(centroid) 1.708 1.702 
Ru(1)–N(1) 2.084(6) 2.0851(17) 
Ru(1)–N(2) 2.083(6) 2.0917(17) 
Ru(1)–N(3) 2.137(7) 2.1242(17) 
C(5)–C(6) 1.457(10) 1.471(3) 
N(1)–Ru(1)–N(2) 77.1(3) 77.30(7) 
N(1)–Ru(1)–N(3) 84.8(2) 88.16(7) 
N(2)–Ru(1)–N(3) 86.6(2) 86.80(7) 
The Ru atom is π-bonded to the arene ligand (p-cymene) and σ coordinated to the nicotinate 
nitrogen and to the two nitrogen atoms of the chelating ligand (bpy) [15]. Nevertheless, there some 
significant differences in the Ru nitrogen bond lengths between the chelating N atoms (2.084(6) Å  
and 2.083(6) Å for 3, and 2.0917(17) Å and 2.0851(17) Å for 4) and the Ru–N bond length of the 
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mono-coordinated N (2.137(7) Å, 2.1242(17) Å) of 3 and 4, respectively. The longer bond length in 
the latter case inferring that it is relatively labile. This was also found to be the case in the analogous 
Ru(II) arene complexes containing N-N chelated ligands [13]. 
Moreover, there are some structural differences between 3 and 4. The presence the methyl ester 
group in the meta position (complex 3) imposes some steric constraints around the central Ru atom, 
resulting in the narrowing of the of the N2A–Ru–N3A bond angle (84.8°) for complex 3, compared to  
N1–Ru–N3 (88.16°) for complex 4. The position of the methyl ester group of the N-σ-donor ligand has 
no influence on the corresponding Ru(II)–arene(centroid) distances (~1.70 Å) and is consistent with the 
values reported for similar complexes [13]. 
Analogues of 1–4 bearing m/p-carboxypyridine (i.e., nicotinic and isonicotinic acid) were found to 
be unstable in DMSO and aqueous solutions in the dark. Dissolution of these compounds in the two 
solvents at 310 K readily gave rise to ligand exchange reactions as indicated by the concomitant 
changes in appearance of a new set of peaks in the 1H-NMR spectra, which correspond to the aqua 
adduct and to signals for either the free nicotinic or isonicotinic acids, as applicable. For example, the 
extent of the hydrolysis for the isonicotic analogue of 4 was already ca. 40%–50% after <15 min as 
observed by 1H-NMR (data not shown). However, the complexes containing the esterified analogues 
i.e., 1–4 were found to be stable towards hydrolysis for over 48 hours under the same experimental 
conditions and were selected for further studies into ligand exchange as a function of photoactivation 
(vide infra). 
2.2. DFT Geometries and Electronic Structures of 1–4 
Geometry optimization of complexes 1–4 was performed for both the ground state and the  
lowest-lying triplet state. Details of the main optimized geometrical parameters are summarized in  
Table 3 and in Supplementary Tables S1–S3. 
Table 3. Selected calculated bond distances (Å) for 1–4 in the ground state (S0) and  
lowest-lying triplet state (T0 and T1) geometries. 
Compound Ru–N(L) Ru–N(N-N) Ru–N(N-N) Ru–arene(centroid) 
S0 
1 2.157 2.111 2.109 1.845 
2 2.147 2.113 2.111 1.850 
3 2.160 2.102 2.098 1.848 
4 2.148 2.104 2.102 1.853 
T0 
1 2.140 2.439 2.130 2.083 
2 2.136 2.454 2.137 2.094 
3 2.152 2.386 2.112 2.092 
4 2.153 2.391 2.110 2.096 
T1 
1 2.556 2.103 2.099 2.123 
2 2.522 2.105 2.093 2.137 
3 2.565 2.084 2.087 2.142 
4 2.532 2.088 2.082 2.153 
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In the ground state (S0), all the complexes have a pseudo-octahedral coordination structure. Bond 
lengths and angles obtained by DFT calculations are in excellent agreement with the experimental  
X-ray diffraction data collected for complexes 3 and 4 (Table 3). 
The lowest-lying triplet state geometries were also optimized, due to the key role that this state can 
play in the photochemistry of Ru(II) arene complexes. The geometry optimization of 1–4 in the triplet 
electronic state led to two distinct triplets, T0 and T1. The former is the actual lowest-lying triplet (T0) 
while the latter (T1) has a slightly higher energy (about 0.1 eV). Frequency calculations confirmed that 
both these geometries correspond to a minimum in the potential energy surface. 
In both T0 and T1 states, 1–4 display a distorted geometry. In T0, complexes have similar  
Ru–N(methyl nicotinate) distances of 2.145 ± 0.009 Å, which resemble those observed in the ground 
state S0 (2.153 ± 0.006 Å), while one of the Ru–N(N-N) bond distances is considerably longer than  
the other, typically ~2.12 and 2.40 Å. In contrast, in the T1 state 1–4 show considerably elongated  
Ru–N(methyl nicotinate) distances (~2.54 Å) and the Ru–N(N-N) distances resemble that obtained for 
the ground state. In both T0 and T1 states, each of the computed Ru–η6-p-cymene(centroid) distances 
are longer than those calculated for the ground state (~2.1 Å). 
Complexes 1–4 display similar frontier molecular orbitals in the S0 state (Figure 3 for 1 and 
Supplementary Figure S2). They all have the HOMO localized on the metal atom and on the  
η6-p-cymene ligand while the LUMO is centred on the 2,2'-bipyrimidine (1, 2) or on the 2,2'-bipyridine 
unit (3, 4). The following four virtual orbitals (from LUMO+1 to LUMO+4) display a σ-antibonding 
feature towards the Ru–N(methyl nicotinate) bond or one of the Ru–N(N-N) bonds. 
 
Figure 3. Selected frontier orbitals for complex 1 in the ground state (S0) geometry. 
In the triplet electronic state (Figure 4 for 3 and Supplementary Figures S4 and S5), the complexes 
display a lowest-SOMO (l-SOMO) delocalized over the whole molecule, both at the lowest-lying 
triplet (T0) optimized geometry and at the T1 optimized geometry. Only for 3 and 4 at the T0 geometry 
the l-SOMO is mainly localized on the N-N chelating ligand. The T0 highest-SOMO (h-SOMO) is 
delocalized over the η6-p-cymene ligand, the Ru atom and the N-N chelating ligand of 1–4 in the 
lowest-lying triplet state. On the contrary, when 1–4 are in the T1 state, their h-SOMO is delocalized 
over the η6-p-cymene ligand, the Ru atom and the methyl nicotinate ligand. In both T0 and T1, the  
h-SOMO of 1–4 has a dissociative nature, due to the σ-antibonding character of this orbital towards 
one of the Ru–N(N-N) bonds (T0 state) or the Ru–N(methyl nicotinate) bond (T1 state). 
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Figure 4. Calculated lowest- and highest-Single Occupied Molecular Orbitals (h-SOMO 
and l-SOMO), for complex 3 in the T0 and T1 optimized geometries. 
2.3. Photophysical and Photochemical Properties of 1–4 
The experimental and calculated UV–vis absorption spectra for 1–4 are reported in Figure 5.  
A complete set of TD-DFT calculations was performed at the B3LYP/LanL2Dz/6-31G** level to 
characterize their singlet excited states and electronic properties. 
 
Figure 5. Experimental (black) and theoretical (light blue) UV-Vis spectra of 1–4 in 
aqueous solution. Calculated singlet-singlet electronic transitions are shown as vertical bars 
with heights equal to their oscillator strength. GaussSum 2.2.5 [10] was used to simulate 
the theoretical UV-Vis spectra (FWHM = 3000 cm−1). 
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According to DFT, the intense absorption bands of 1–4 in the high energy range (ca. 340–250 nm) 
are described by a series of metal-to-ligand charge transfer (1MLCT) transitions alternated with few 
intense transitions having a pronounced interligand (1IL) or ligand-centered (1LC) character. 
The absorbance tail in the 380–450 nm region is dominated by metal-to-ligand charge transfer 
(1MLCT) transitions. Some of these transitions are partially dissociative, since they have significant 
contributions from the Ru–N(N-N) and Ru–N(L) σ-antibonding orbitals. 
Electron density difference maps (EDDMs) were used to visualize the character associated with the 
given transition. EDDMs are obtained subtracting the initial electron density of 1–4 (i.e., before the 
electronic transition) to their electron density in the excited state (i.e., after the electronic transition). 
Selected EDDMs for complex 1 are shown in Figure 6 as an example and in the Supporting 
Information (Supplementary Figures S6–S9) section for a full account. The orbital compositions of 
computed singlet transitions for all complexes are reported in Supplementary Tables S5–S8. 
 
Figure 6. Selected electron density difference maps (EDDMs) of singlet excited state 
transitions of 1 in water (B3LYP/LANL2DZ/6-31G** level, PCM method). Light green 
indicates a decrease in electron density, while green indicates an increase. 
In aqueous solution both sets of complexes behave similarly upon light irradiation (λexc = 400 nm). 
As observed previously [13,14], the monodentate pyridyl ligands are released and formation of the 
aqua complexes [(η6-p-cym)Ru(N-N)(OH2)]2+ is observed. The reaction progression is easily monitored by 
UV-Vis following the decrease in intensity of the bands in the UV spectrum and the increase of the 
absorption at λ > 400 nm (Figure 7). The presence of pseudoisosbestic points indicates the photosubstitution 
reaction is clean, giving only a single photoproduct, as confirmed by the NMR photolysis experiment 
reported for complex 1 (Figure 8). Indeed, new sets of NMR signals are formed upon light excitation, 
corresponding to [(η6-p-cym)Ru(N-N)(OH2]2+ complexes and free m-COOCH3-Py. Estimation of the 
photosubstitution yields with actinometry indicated that complexes 1–4 are modestly photoreactive, 
since they display yields smaller than 1% (Supplementary Table S9). 
As shown by the TD-DFT calculations, the selective photochemical dissociation of the methyl 
nicotinate ligand is consistent with the presence of σ-antibonding orbitals that participate in several 
singlet transitions. In particular, the antibonding orbitals L+1 and L+3 participate in all the transitions 
between 300 and 440 nm of 1. Similarly, the antibonding orbital L+4 is involved in all the transitions 
between 330 and 440 nm of 2. In the case of 3, only few transitions involve the antibonding orbital 
L+3. Finally, in the case of the less photoactive complex (4), there are no contributions from the 
antibonding orbital L+1 to low energy transitions (over 330 nm). 
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Figure 7. Photolysis (λexc = 400 nm, 2 mW·cm−2) of complexes 1–4 (60 μM) in aqueous 
solution followed by UV-Vis. 
 
Figure 8. Photolysis (λexc = 400 nm, 2 mW·cm−2) of complex 1 (ca. 300 μM) in aqueous 
solution (1%–5% DMSO) followed by 1H-NMR spectroscopy. The grey panel highlights 
the disappearance of the bpm signal relative to the proton in position 6,6' for 1 and the 
appearance of the analogue signal for its aqua derivative [(η6-p-cym)Ru(bpm)H2O]2+. 
On the basis of the DFT results, as well as modest photochemistry rates [13,14], triplet states are 
believed to play a key role in the ligand photodissociation mechanism of these Ru(II) arene complexes. 
The distorted geometry, exhibited by 1–4 in their T0 and T1 states, can be ascribed to the population of 
σ-antibonding h-SOMOs, involving one Ru–N bond. In the lowest-lying triplet state T0, the dissociation 
of the chelating ligand is prevented by the strong coordination of the other ring to the Ru atom, which 
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makes this state less likely to prompt release of ligands [16,17]. On the contrary, the elongation of the 
Ru–N(methyl nicotinate) bond of 1–4 in the T1 state can be related to the dissociation of the methyl 
nicotinate units. Spin density surfaces (Supplementary Figure S10) show that the nature of the 
dissociative (T1) and nondissociative (T0) states of all the complexes is 3MC. The nondissociative 
3MC states (T0) are responsible for the return of the excited molecules to the ground state, while the 
dissociative 3MC states cause the selective dissociation of the methyl nicotinate ligand. 
3. Experimental Section 
3.1. General Information 
RuCl3·3H2O was purchased from Precious Metals Online (PMO Pty Ltd., Wollongong, Australia) 
and used as received. 2,2'-bipyrimidine (bpm), 2,2'-bipyridine (bpy) silver nitrate (AgNO3), potassium 
hexafluorophosphate (KPF6), isonicotinic acid, nicotinic acid, methyl nicotinate, methyl isonicotinate 
were obtained from Sigma-Aldrich (St. Louis, MO, USA). The dimer [(η6-p-cym)RuCl2]2 was prepared 
based on literature methods [18,19]. The Ru(II) arene complexes [(η6-p-cym)Ru(bpm)Cl][PF6] and  
[(η6-p-cym)Ru(bpy)Cl][PF6] were synthesised following a method previously described [15]. UV-Vis 
absorption spectra were recorded on a Cary 5000 spectrophotometer (Agilent Technologies, Santa Clara, 
CA, USA) using 1-cm path length quartz cuvettes (1 mL) and a PTP1 Peltier temperature controller. 
Spectra were recorded at 310 K in deionized water from 200 to 800 nm. 1H and 13C-NMR spectra were 
acquired in 5 mm NMR tubes at 298 K (unless otherwise stated) on a Bruker Avance 500 NMR 
spectrometer (Bruker Corporation, Billerica, MA, USA). 1H chemical shifts were internally referenced 
to TMS via residual DMSO (δ 2.50). 1D spectra were recorded using standard pulse sequences. 
Photolysis studies were performed by irradiating aqueous solutions (1%–5% DMSO) of complexes 1–4 
with a Xe lamp (KiloArc) at 400 nm (2 mW·cm−2). Formation of photoproducts was monitored by 
UV-vis spectroscopy (60 μM) and by NMR (300 μM). The quantum yields (Φ) for photoinduced ligand 
substitution of 1–4 were determined by ferrioxalate actinometry [20] under 395-nm light irradiation, 
using a MWLLS-11 Fiber Coupled 11 LED Multi-Wavelength LED Light Source (15.1 mW·cm−2) by 
Prizmatix Ltd (Givat-Shmuel, Israel). Details are reported in the Supporting Information. Elemental 
analyses were performed by the Warwick Analytical Service, which is the analytical division of Exeter 
Analytical Ltd, using a CE440 Elemental Analyzer (Exeter Analytical Ltd, Coventry, UK). 
3.2. Synthesis 
The complexes 1–4 were synthesised using a similar procedure previously reported [21]. An 
aluminium-foil-covered round bottom flask was charged with [(η6-p-cym)Ru(bpy)Cl][PF6] and a 1 mol 
equivalent of AgNO3 in a 1:1 mixture of MeOH/H2O (10 mL) and the reaction mixture stirred at 323 K 
(4 h). Precipitated AgCl was then removed by filtration. To the clear filtrate up to 10 mol equivalents 
of the appropriate pyridine derivative was added and the reaction mixture left stirring overnight at 
ambient temperature. The volume of the reaction mixture was reduced by rotary evaporation and up to 
5 mol equivalents of KPF6 was added. The precipitate that formed was filtered and redissolved by the 
addition of acetone and the clear reaction mixture was left to evaporate slowly at ambient temperature. 
The crystalline materials that were formed were collected by filtration, washed with methanol and 
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ether and dried in air. Quantitative details of the preparations and the nature of the product of the 
individual reactions are described below. 
3.2.1. [(η6-p-cym)Ru(bpm)(m-COOMe-Py)]2+ (1) 
The complex was prepared as described above: AgNO3 (0.029 g, 0.174 mmol), MeOH/H2O (1:1,  
20 mL), [(η6-p-cym)Ru(bpm)Cl][PF6] (0.10 g, 0.174 mmol). To the clear solution of [(η6-p-cym) 
Ru(bpm)H2O]2+, methyl-nicotinate (0.120 g, 0.87 mmol) and KPF6 (0.220 g, 1.2 mmol) was added. 
Red crystals were obtained. Yield: (72 mg, 40%). 1H-NMR (D2O/DMSO-d6 (5%), ppm) δ: 10.02 (dd, 
bpm, 3JHH = 5.8 and 2.0 Hz, 2H), 9.24 (dd, bpm, 3JHH = 4.8 and 1.9 Hz, 2H), 8.59 (d, R-Py, 3JHH = 6.1 Hz, 
2H), 8.11 (dd, bpm, 3JHH = 5.9 and 4.8 Hz, 2H), 7.85 (d, R-Py, 3JHH = 6.1 Hz, 2H), 6.47 (d, p-cym, 
3JHH = 6.5 Hz, 2H), 6.16 (d, p-cym, 3JHH = 6.5 Hz, 2H), 3.85 (s, COOCH3, 3H), 2.42 (hept, p-cym CH, 
3JHH = 7.0 Hz, 1H), 1.79 (s, p-cym CH3, 3H), 0.88 (d, p-cym CH3, 3JHH = 6.9 Hz, 6H). 13C-NMR 
(DMSO-d6, ppm) δ: 164.2, 164.1, 161.5, 160.7, 155.1, 140.0, 126.1, 125.8, 107.6, 106.7, 90.8, 86.2, 
53.8, 30.4, 22.2, 17.8. Elemental Analysis: Calculated for C26H29F12N3O2P2Ru.0.5(CH3)2CO: H 3.73, C 
39.52, N 5.03; found H 3.35, C 39.48, N 4.99. 
3.2.2. [(η6-p-cym)Ru(bpm)(p-COOMe-Py)]2+ (2) 
The complex was prepared as described above: AgNO3 (0.029 g, 0.174 mmol), MeOH/H2O (1:1,  
20 mL), [(η6-p-cym)Ru(bpm)Cl][PF6] (0.10 g, 0.174 mmol). To the clear solution of [(η6-p-cym) 
Ru(bpm)H2O]2+, methyl-isonicotinate (0.120 g, 0.87 mmol) and KPF6 (0.220 g, 1.2 mmol) was then 
added. Reddish yellow crystals were obtained. Yield: (42 mg, 29%). 1H-NMR (D2O/DMSO-d6 (5%), 
ppm) δ: 10.07 (dd, bpm, 3JHH = 5.8 and 1.9 Hz, 2H), 9.25 (dd, bpm, 3JHH = 4.8 and 1.9 Hz, 2H), 8.85 
(s, R-Py, 1H), 8.55 (d, R-Py, 3JHH = 5.7 Hz, 1H), 8.42 (d, R-Py, 3JHH = 8.0 Hz, 1H), 8.13 (dd, bpm, 
3JHH = 5.8 and 4.8 Hz, 2H), 7.53 (t, R-Py, 3JHH = 8.1 and 5.8 Hz, 1H), 6.48 (d, p-cym, 3JHH = 6.5 Hz, 
2H), 6.18 (d, p-cym, 3JHH = 6.5 Hz, 2H), 3.87 (s, COOCH3, 3H), 2.43 (hept, p-cym CH, 3JHH = 7.0 Hz, 
1H), 1.80 (s, p-cym CH3, 3H), 0.88 (d, p-cym CH3, 3JHH = 6.8 Hz, 6H).13C-NMR (DMSO-d6, ppm) δ: 
164.0, 161.6, 160.9, 157.3, 153.9, 140.5, 128.9, 127.4, 126.0, 107.5, 106.5, 90.6, 86.2, 56.5, 53.5, 30.4, 
22.2, 19.0, 17.8. Elemental Analysis: Calculated for C26H29F12N3O2P2Ru. 0.5(CH3)2CO: H 3.73, C 
39.52, N 5.03; found H 3.34, C 39.44, N 5.01. 
3.2.3. [(η6-p-cym)Ru(bpy)(m-COOMe-Py)]2+ (3) 
The complex was prepared as described above: AgNO3 (0.04 g, 0.235 mmol), MeOH/H2O (1:1,  
20 mL), [(η6-p-cym)Ru(bpy)Cl][PF6] (0.10 g, 0.175 mmol). To the clear solution of [(η6-p-cym) 
Ru(bpy)H2O]2+, methyl-nicotinate (0.165 g, 1.2 mmol) and KPF6 (0.220 g, 1.2 mmol) was then added. 
The yellow needles obtained were collected by filtration and washed with methanol and ether and 
dried in air in the dark. Some of the crystals were used for single crystal X-ray analysis. Yield: (72 mg, 
50%). 1H-NMR (D2O/DMSO-d6 (5%), ppm) δ: 9.70 (d, bpy, 3JHH = 7.4 Hz, 2H), 8.80 (s, R-Py, 1H), 
8.55 (d, R-Py, 3JHH = 5.5 Hz, 1H), 8.37 (dt, R-Py, 3JHH = 8.1 and 1.7 Hz, 1H), 8.30 (d, bpy, 3JHH = 8.0 Hz, 
2H), 8.23 (td, bpy, 3JHH = 8.0 and 1.5 Hz, 2H), 7.90 (td, bpy, 3JHH = 7.4 and 1.5 Hz, 2H), 7.47 (dd,  
R-Py, 3JHH = 8.1 and 5.8 Hz, 1H), 6.44 (d, p-cym, 3JHH = 6.4 Hz, 2H), 6.05 (d, p-cym, 3JHH = 6.4 Hz, 
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2H), 3.85 (s, COOCH3, 3H), 2.42 (hept, p-cym CH, 3JHH = 7.0 Hz, 1H), 1.77 (s, p-cym CH3, 3H), 0.83 
(d, p-cym CH3, 3JHH = 6.9 Hz, 6H). 13C-NMR (DMSO-d6, ppm) δ: 163.5, 156.9, 156.6, 155.4, 152.8, 
141.8, 140.7, 129.5, 128.9, 127.5, 125.2, 108.6, 103.8, 92.3, 85.1, 53.5, 30.6, 22.2, 17.9. Elemental 
Analysis: Calculated for C24H27F12N5O2P2Ru. 0.5(CH3)2CO: H 3.60, C 36.56, N 8.36; found H 3.29, C 
36.32, N 8.16. 
3.2.4. [(η6-p-cym)Ru(bpy)(p-COOMe-Py)]2+ (4) 
The complex was prepared in an identical manner as described for 3. Red crystals were collected by 
filtration and washed with methanol and ether and dried in air in the dark. Some of the crystals were 
used for single crystal X-ray analysis. Yield: (50 mg, 35%). 1H-NMR (D2O/DMSO-d6 (5%), ppm) δ: 
9.66 (d, bpy, 3JHH = 5.9 Hz, 2H), 8.57 (d, R-Py, 3JHH = 7.0 Hz, 2H), 8.30 (d, bpy, 3JHH = 8.1 Hz, 2H), 8.23 
(t, bpy, 3JHH = 7.7 Hz, 2H), 7.88 (t, bpy, 3JHH = 6.0 Hz, 2H), 7.80 (d, R-Py, 3JHH = 7.0 Hz, 2H), 6.43 (d, 
p-cym, 3JHH = 6.4 Hz, 2H), 6.02 (d, p-cym, 3JHH = 6.4 Hz, 2H), 3.84 (s, COOCH3, 3H), 2.41 (hept,  
p-cym CH, 3JHH = 7.0 Hz, 1H), 1.75 (s, p-cym CH3, 3H), 0.83 (d, p-cym CH3, 3JHH = 6.9 Hz, 6H).  
13C-NMR (DMSO-d6, ppm) δ: 164.0, 156.7, 155.3, 154.4, 141.7, 140.3, 129.6, 125.9, 125.1, 108.7, 
104.1, 92.5, 85.1, 53.7, 30.6, 22.2, 17.9. Elemental Analysis: Calculated for C24H27F12N5O2P2Ru. 
0.5(CH3)2CO: H 3.60, C 36.56, N 8.36; found H 3.27, C 36.56, N 8.42. 
3.3. X-ray Crystallography 
Diffraction data were collected on Agilent Super Nova Mo-diffractometer (Agilent Technologies, 
Santa Clara, CA, USA), equipped with CCD area detector, at a temperature of 100 K, equipped with an 
Agilent 700 Cryosystem Cryostream Cooler fed with liquid nitrogen. All structures were refined by  
full-matrix least squares against F2 using SHELXL-97 [22] and were solved by direct methods [23–25]. 
Hydrogen atoms were added at calculated positions and refined using a riding model. X-ray 
crystallographic data for complexes 3 and 4 have been deposited in the Cambridge Crystallographic 
Data Centre under the accession numbers CCDC 1018418 and 1018419, respectively.  
3.4. Computational Details 
All calculations were performed with the Gaussian 09 (G09) program package [26], employing the 
DFT and TD-DFT methods [27,28], the Becke three-parameter hybrid functional [29], and the  
Lee-Yang-Parr’s gradient corrected correlation functional (B3LYP) [30]. The solvent effect was 
included using the polarizable continuum model (PCM method) [31,32], with water as solvent. The 
LanL2DZ basis set [33] and effective core potential were used for the Ru atom and the 6-31G** basis 
set [34] was used for all the other atoms. The B3LYP/LanL2DZ/6-31G** combination was selected 
since it previously provided satisfactory results on similar ruthenium arene complexes [13,14]. 
Geometry optimizations (ground state (S0), lowest-lying triplet state (T0 and T1)) were carried out 
without any symmetry constraints, the nature of all stationary points was confirmed by normal-mode 
analysis and no imaginary frequencies were found. 
The UV-Vis electronic absorption spectra were simulated by TD-DFT [27,28], computing a total of 
50 singlet excited states. Eight triplet excited states were calculated by TD-DFT using the lowest-lying 
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triplet state geometry. The electronic distribution and the localization of the singlet and triplet excited 
states were visualized using electron density difference maps (EDDMs). 
GaussSum 2.2.5 [35] was used to simulate the theoretical UV-Vis spectra and for EDDMs 
calculations [36,37]. Molecular graphics images were produced using the UCSF Chimera package 
from the Resource for Biocomputing, Visualization, and Informatics at the University of California, 
San Francisco (supported by NIH P41 RR001081) [38]. A full summary of the computational results is 
reported in the Supporting Information. 
4. Conclusions 
Several new Ru(II) arene complexes of formula [(η6-p-cym)Ru(N-N)(X)]2+(where p-cym = para-cymene, 
N-N = bpm or bpy and X = m/o-substituted pyridine) have been synthesised and characterized in this 
work, including the X-ray structure of two of them, namely [(η6-p-cym)Ru(bpy)(m-COOCH3-Py)]2+ 
(3) and[(η6-p-cym)Ru(bpy)(p-COOCH3-Py)]2+ (4). Pyridyl ester derivatives (1–4) are stable in aqueous 
solution and do not hydrolyze in the dark within the monitored period (48 h). On the contrary, their 
carboxylic analogues are not stable in the dark and readily dissociate the pyridyl ligand affording the 
[(η6-p-cym)Ru(N-N)(OH2)]2+ complex. This is a crucial discovery for the design of novel 
photoactivatable Ru(II) arene complexes which are required to be substitutionally inert in the dark 
since there are evidences that aqua species play a fundamental role in their cytotoxicity mechanism [39]. 
Moreover, such result highlights how a subtle change in the electronic structure of the periphery of the 
monodentate pyridyl ligand (COOMe vs COOH) can affect the overall stability of the complex. 
Notably, pyridyl esters could also offer new synthetic routes for functionalization of Ru(II) arene 
complexes with dyes [40] or targeting/anchoring groups suitable for coupling to proteins or decoration 
of nanoparticles, strategies that could be used to favour the cellular delivery of this class of agents. 
Finally, DFT calculations provided a valuable rationalization of the photochemistry of complexes  
1–4, pinpointing for the first time that the dissociative ll-T1 triplet state is likely to be responsible for 
the selective light-induced ejection of the monodentate pyridyl ligand. 
Supplementary Materials 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/20/04/7276/s1. 
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